Cyclophilin-A: a novel biomarker for untreated male essential hypertension

References

• Arora K, Gwinn WM, Bower MA, et al. (2005). Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 175:517–22
   PubMed Web of Science ®Google Scholar
• Bermudez EA, Rifai N, Buring J, et al. (2002). Interrelationships among circulating interleukin (IL)-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22:1668–73
   PubMed Web of Science ®Google Scholar
• Blann AD, Tse W, Maxwell SJ, Waite MA. (1994). Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 12:925–8
   PubMed Web of Science ®Google Scholar
• Brown CD, Higgins M, Donato KA, et al. (2000). Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 8:605–19
   PubMedGoogle Scholar
• Chrysohoou C, Pitsavos C, Panagiotakos DB, et al. (2004). Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA study. Am J Hypertens 17:568–73
   PubMed Web of Science ®Google Scholar
• Davey Smith G, Lawlor DA, Harbord R, et al. (2005). Association of c-reactive protein with blood pressure and hypertension. Arteriosclerosis Thromb Vascular Biol 25:1051–60
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 8:499–502
   Google Scholar
• Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–8
   PubMed Web of Science ®Google Scholar
• Handschumacher RE, Harding MW, Rice J, et al. (1984). Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544–7
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Ballantyne CM, Sharrett AR, et al. (1997). Circulating adhesion molecules VCAM-a, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 96:4219–25
   PubMed Web of Science ®Google Scholar
• Iiyama K, Nagano M, Yo Y, et al. (1996). Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 132:779–82
   PubMed Web of Science ®Google Scholar
• Jin ZG, Melaragno MG, Liao DF, et al. (2000). Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 87:789–96
   PubMed Web of Science ®Google Scholar
• Kato N, Sugiyama T, Morita H, et al. (1999). Lack of evidence for association between the eNOS gene and hypertension. Hypertension 33:933–6
   PubMed Web of Science ®Google Scholar
• Komatsu S, Panés J, Russell JM, et al. (1997). Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecule-1 expression in vivo. Hypertension 29:683–9
   PubMed Web of Science ®Google Scholar
• Kummayinka SK. (1997). The impact of obesity on hypertension management in African Americans. J Healthcare Poor Underserved 8:352–64
   PubMedGoogle Scholar
• Kuroda YT, Komamura K, Tatsumi R, et al. (2001). Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension. Am J Hypertens 14:868–72
   PubMed Web of Science ®Google Scholar
• Lacy F, O’Connor DT, Schmid-Schonbein GW. (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at enetic risk of hypertension. J Hypertension 16:291–303
   PubMed Web of Science ®Google Scholar
• Lim CS, Shalhoub J, Gohel MS, et al. (2010). Matrix metalloproteinases in vascular disease–a potential therapeutic target?. Curr Vasc Pharmacol 8:75–85
   PubMed Web of Science ®Google Scholar
• Li-Saw-Hee FL, Edmunds E, Blann AD, et al. (2000). Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol 75:43–7
   PubMed Web of Science ®Google Scholar
• McGowan MW, Artiss JD, Strandbergh DR, Zak B. (1983). A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29:538–42
   PubMed Web of Science ®Google Scholar
• Miller MA, Kerry SM, Cook DG, Cappuccio FP. (2004). Cellular adhesion molecules and blood pressure interaction with sex in a multiethnic population. J Hypertens 22:705–11
   PubMedGoogle Scholar
• Nigro P, Satoh K, O'Dell MR, et al. (2011). Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 208:53–66
   PubMed Web of Science ®Google Scholar
• Oparil S, Zaman MA, Calhoun DA. (2003). Pathogenesis of hypertension. AnnIntern Med 139:761–76
   Google Scholar
• Olsen MH, Wachtell K, Aalkjaer C, et al. (2002). Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am J Hypertens 15:398–404
   PubMedGoogle Scholar
• Onal IK, Altun B, Onal ED, et al. (2009). Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment. Eur J Intern Med 20:369–72
   PubMedGoogle Scholar
• Panek AN, Bader M. (2006). Matrix reloaded: the matrix metalloproteinase paradox. Hypertension 47:640–1
   PubMedGoogle Scholar
• Pi-Sunyer FX. (1993). Medical hazards of obesity. Ann Intern Med 119:655–60
   PubMed Web of Science ®Google Scholar
• Satoh K, Matoba T, Suzuki J, et al. (2008). Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 117:3088–98
   PubMed Web of Science ®Google Scholar
• Satoh K, Nigro P, Berk BC. (2010). Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal 12:675–82
   PubMedGoogle Scholar
• Satoh K, Nigro P, Matoba T, et al. (2009). Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 15:649–56
   PubMed Web of Science ®Google Scholar
• Tuttle RS, Boppana DP. (1990). Antihypertensive effect of interleukin-2. Hypertension 15:89–94
   PubMed Web of Science ®Google Scholar
• Touyz RM. (2000). Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2:98–105
   PubMedGoogle Scholar
• Warnick GR, Benderson J, Albers JJ. (1982). Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28:1379–88
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu N, Zhou J, et al. (2008). Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 47:1299–310
   PubMed Web of Science ®Google Scholar